Skip to main content

Table 5 Adverse event(s) charted at index therapy change within 6 months and full study period among patients who changed, N (%)

From: A multicenter, retrospective chart review study comparing index therapy change rates in open-angle glaucoma or ocular hypertension patients newly treated with latanoprost or travoprost-Z monotherapy

 

Within 6 months

Across full study period

 

Latanoprost

N = 134

Travoprost-Z

N = 77

Latanoprost

N = 218

Travoprost-Z

N = 121

Hyperemia†

7 (5.2)

18 (23.4)

10 (4.6)

21 (17.4)

Burning

7 (5.2)

2 (2.6)

10 (4.6)

2 (1.7)

Pain/ocular discomfort

4 (3.0)

3 (3.9)

4 (1.8)

4 (3.3)

Blepharitis

3 (2.2)

2 (2.6)

4 (1.8)

2 (1.7)

Dry eye

1 (0.7)

1 (1.3)

3 (1.4)

4 (3.3)

Foreign body sensation

1 (0.7)

2 (2.6)

2 (0.9)

4 (3.3)

Pruritis

1 (0.7)

0

7 (3.2)

1 (0.8)

Other

8 (6.0)

8 (10.4)

16 (7.3)

10 (8.3)

  1. *Reported by ≥2% of patients in either cohort at either time point. More than one event could be reported for each patient.
  2. †p < 0.0001 for both within six months and across full study period.